Current and historical daily PE Ratio for Corcept Therapeutics Inc (
LTS:0I3Q
) from 2018 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Corcept Therapeutics stock (LTS:0I3Q) PE ratio as of May 23 2024 is 27.
More Details
Corcept Therapeutics Inc (LTS:0I3Q) PE Ratio (TTM) Chart
Corcept Therapeutics Inc (LTS:0I3Q) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1281
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Corcept Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | 26.3 | 2024-03-22 | 25.6 |
| 2024-05-23 | 26.3 | 2024-03-21 | 26.2 |
| 2024-05-22 | 27.1 | 2024-03-20 | 26.1 |
| 2024-05-21 | 27.4 | 2024-03-19 | 25.5 |
| 2024-05-20 | 27.5 | 2024-03-18 | 25.7 |
| 2024-05-17 | 26.4 | 2024-03-15 | 23.9 |
| 2024-05-16 | 26.1 | 2024-03-14 | 24.8 |
| 2024-05-15 | 26.3 | 2024-03-13 | 25.4 |
| 2024-05-14 | 25.6 | 2024-03-12 | 25.3 |
| 2024-05-13 | 26.4 | 2024-03-11 | 24.9 |
| 2024-05-10 | 25.6 | 2024-03-08 | 24.9 |
| 2024-05-09 | 24.6 | 2024-03-07 | 24.4 |
| 2024-05-08 | 23.0 | 2024-03-06 | 24.0 |
| 2024-05-07 | 23.0 | 2024-03-05 | 24.3 |
| 2024-05-06 | 22.6 | 2024-03-04 | 25.3 |
| 2024-05-03 | 22.6 | 2024-03-01 | 25.6 |
| 2024-05-02 | 23.1 | 2024-02-29 | 24.8 |
| 2024-05-01 | 22.2 | 2024-02-28 | 25.5 |
| 2024-04-30 | 22.4 | 2024-02-27 | 25.7 |
| 2024-04-29 | 22.1 | 2024-02-26 | 24.6 |
| 2024-04-26 | 21.8 | 2024-02-23 | 23.8 |
| 2024-04-25 | 21.0 | 2024-02-22 | 23.9 |
| 2024-04-24 | 21.0 | 2024-02-21 | 23.1 |
| 2024-04-23 | 22.7 | 2024-02-20 | 24.0 |
| 2024-04-22 | 21.4 | 2024-02-19 | 24.2 |
| 2024-04-19 | 21.6 | 2024-02-16 | 24.2 |
| 2024-04-18 | 21.6 | 2024-02-15 | 26.2 |
| 2024-04-17 | 21.5 | 2024-02-14 | 25.6 |
| 2024-04-16 | 22.2 | 2024-02-13 | 24.3 |
| 2024-04-15 | 21.7 | 2024-02-12 | 25.1 |
| 2024-04-12 | 22.2 | 2024-02-09 | 24.1 |
| 2024-04-11 | 22.2 | 2024-02-08 | 23.6 |
| 2024-04-10 | 22.3 | 2024-02-07 | 23.3 |
| 2024-04-09 | 23.4 | 2024-02-06 | 23.1 |
| 2024-04-08 | 23.0 | 2024-02-05 | 22.7 |
| 2024-04-05 | 23.6 | 2024-02-02 | 22.3 |
| 2024-04-04 | 24.1 | 2024-02-01 | 23.4 |
| 2024-04-03 | 23.8 | 2024-01-31 | 22.4 |
| 2024-04-02 | 23.7 | 2024-01-30 | 22.6 |
| 2024-04-01 | 23.8 | 2024-01-29 | 23.3 |
| 2024-03-29 | 23.8 | 2024-01-26 | 23.0 |
| 2024-03-28 | 23.8 | 2024-01-25 | 24.2 |
| 2024-03-27 | 26.4 | 2024-01-24 | 24.5 |
| 2024-03-26 | 26.0 | 2024-01-23 | 24.4 |
| 2024-03-25 | 25.6 | 2024-01-22 | 24.8 |
Corcept Therapeutics Inc (LTS:0I3Q) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Corcept Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US2183521028
Share Class Description:
LTS:0I3Q: Ordinary SharesDescription
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers